Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950103-26-017513·Boehler Adam
Schedule 13G ownership disclosure
Evolent Health Inc
Class A Common Stock · CUSIP: 30050B101
Event date: 2026-09-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Rubicon Fund II LP
Shares: 4,947,404.00 · Class: 4.38%
- Rubicon Fund II PF LP
Shares: 693,719.00 · Class: 0.61%
- Rubicon OP GP II LP
Shares: 5,641,123.00 · Class: 4.99%
- Rubicon OP GP II LLC
Shares: 5,641,123.00 · Class: 4.99%
- Rubicon Founders LLC
Shares: 5,641,123.00 · Class: 4.99%
- Boehler Adam
Shares: 5,641,123.00 · Class: 4.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950103-26-017513
- Form type
- SCHEDULE 13G/A
- Filer
- Boehler Adam
- CIK
- CIK 1982325
- Filed
- Nov 13, 2026
- Reporting period
- Sep 09, 2026
- Description
- Schedule 13G beneficial ownership